Plus Therapeutics (PSTV) Amortization - Intangibles (2016 - 2019)
Plus Therapeutics (PSTV) reported Amortization - Intangibles of $306000.0 for Q1 2019, little changed year-over-year from $306000.0 in Q1 2018, and little changed quarter-over-quarter from $306000.0 in Q4 2018.
Plus Therapeutics (PSTV) Amortization - Intangibles (2016 - 2019) Analysis & Trends
Plus Therapeutics (PSTV) has 4 years of Amortization - Intangibles data on file, last reported at $306000.0 in Q1 2019.
- Amortization - Intangibles for Q1 2019 came in at $306000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2019 was $1.2 million (changed 0.0% YoY), and the FY2018 annual result was $1.2 million, changed 0.0% from the prior year.
- Amortization - Intangibles steadied at $306000.0 in Q1 2019 per PSTV's latest filing, from $306000.0 in the prior quarter.
- Over five years, Amortization - Intangibles peaked at $347000.0 in Q4 2016 and troughed at $57000.0 in Q3 2016.
- A 4-year average of $256846.2 and a median of $306000.0 in 2017 frame the typical range for Amortization - Intangibles.
- On a YoY basis, Amortization - Intangibles climbed as much as 436.84% in 2017 and fell as far as 11.82% in 2017.
- A 4-year view of Amortization - Intangibles shows it stood at $347000.0 in 2016, then slipped by 11.82% to $306000.0 in 2017, then changed by 0.0% to $306000.0 in 2018, then changed by 0.0% to $306000.0 in 2019.
- Business Quant data shows PSTV's Amortization - Intangibles at $306000.0 in Q1 2019, $306000.0 in Q4 2018, and $306000.0 in Q3 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 306,000.00 |
| Dec 31, 2018 | 306,000.00 |
| Sep 30, 2018 | 306,000.00 |
| Jun 30, 2018 | 306,000.00 |
| Mar 31, 2018 | 306,000.00 |
| Dec 31, 2017 | 306,000.00 |
| Sep 30, 2017 | 306,000.00 |
| Jun 30, 2017 | 306,000.00 |
| Mar 31, 2017 | 306,000.00 |
| Dec 31, 2016 | 347,000.00 |
| Sep 30, 2016 | 57,000.00 |
| Jun 30, 2016 | 82,000.00 |
| Mar 31, 2016 | 99,000.00 |